CYC.AX

Cyclopharm Limited
ASXAUDEQUITY DELAYED
Last price
0.50
▲ 0.03 (6.45%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.49
Prev close
0.47
Day high
0.50
Day low
0.49
Volume
22.31K
Market cap
P/E (TTM)
52W range
0.45 – 1.29

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-3.88% -2.5%
1M
-12.39% -16.1%
3M
-30.28% -33.4%
6M
-41.76% -52.8%
YTD
-49.49% -61.8%
1Y
-49.49% -69.5%
3Y
-80.04% -154.2%
5Y
-70.00%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on CYC.AX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 2 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $16.69M$27.57M$26.34M$23.22M -39.5%
Operating revenue $16.69M$27.57M$26.34M$23.22M -39.5%
Cost of revenue $14.47M$9.64M$10.26M$7.44M +50.1%
Gross profit $2.22M$17.93M$16.08M$15.78M -87.6%
Research & development $614.69K$365.02K$3.69M$3.44M +68.4%
Selling, general & admin $26.23M$24.62M$16.05M$13.89M +6.5%
Total operating expense $36.04M$32.46M$26.11M$23.41M +11.0%
Operating income -$33.82M-$14.52M-$10.02M-$7.63M -132.8%
Net interest income -$324.10K$350.55K$273.18K-$156.19K -192.5%
Pre-tax income -$17.86M-$13.07M-$4.19M-$6.03M -36.6%
Tax provision -$636.78K$126.17K$511.08K$581.67K -604.7%
Net income -$17.22M-$13.20M-$4.70M-$6.61M -30.5%
Net income to common -$17.22M-$13.20M-$4.70M-$6.61M -30.5%
Basic EPS -0.16-0.13-0.05-0.07 -21.9%
Diluted EPS -0.16-0.13-0.05-0.07 -21.9%
EBIT -$17.81M-$13.04M-$4.17M-$5.96M -36.6%
EBITDA -$16.04M-$11.56M-$3.23M-$5.03M -38.8%
Basic shares 110.13M102.90M92.66M92.18M +7.0%
Diluted shares 110.13M102.90M92.66M92.18M +7.0%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.51
-3.51% from price
SMA 20
0.54
-7.61% from price
SMA 50
0.53
-6.64% from price
SMA 100
0.63
-21.89% from price
SMA 200
0.75
-34.06% from price
EMA 12
0.51
-3.32% from price
EMA 26
0.53
-6.48% from price
EMA 50
0.56
-10.96% from price
RSI (14)
42.4
Neutral
MACD (12,26,9)
-0.02
Hist -0.01
ATR (14)
0.03
5.77% of price
Realised vol 30D
95.4%
Annualised
Bollinger upper
0.60
20, 2σ
Bollinger lower
0.47
20, 2σ
50 / 200 cross
Death
0.53 vs 0.75
Trend bias
Below 200
-34.06%

Options chain

Account required
ExpirySpot 0.50
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.38
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
95.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-62.6%
Peak to trough
Max drawdown 5Y
-84.1%
Peak to trough
ATR 14
0.03
5.77% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.